Mount Yale Investment Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-10,000
Closed -$8.07K – 519
2023
Q3
$8.07K Buy
+10,000
New +$559K ﹤0.01% 496

Other funds holding GMED

Mount Yale Investment Advisors's GMED Position: Q2 2026 in Review

Mount Yale Investment Advisors opened a new position in Globus Medical (GMED) in Q2 2026: 3,442 shares worth $272K. The stake represents 0.01% of the portfolio and ranks #1016 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in GMED as recently as Q3 2024.

Mount Yale Investment Advisors first reported a position in GMED in Q1 2018 and has held it in 25 quarters since. The position peaked at $1.09M in Q2 2021. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Mount Yale Investment Advisors held 3,442 shares of Globus Medical worth $272K as of Q2 2026.
  • Globus Medical was a new Mount Yale Investment Advisors position in Q2 2026.
  • Globus Medical made up 0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #1016 holding.
  • Mount Yale Investment Advisors first reported a position in Globus Medical in Q1 2018 and has held it in 25 quarters since.
  • Mount Yale Investment Advisors's Globus Medical position peaked at $1.09M in Q2 2021.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.